Allergen testing in the food industry relies on the use of generic immunoassays for allergens and other antigens or residues within the food to provide a measure of total food allergen content (usually expressed in parts per million). This approach serves the purpose of having a test that can measure allergenic foods (eg, peanut, milk, egg, soy, and shellfish) that might contaminate the food supply and put allergic patients at risk of having symptoms.
From an allergy perspective, generic ELISAs for foods have several limitations. The specific food allergens/antigens that are measured in these assays are not defined, and assays from different manufacturers cannot be directly compared. The inability to measure specific allergens means that the tests cannot discriminate between specific allergen levels in food products or in food preparations that are increasingly being used for oral immunotherapy (OIT) or for prophylactic approaches to food allergy prevention. [1] [2] [3] [4] The allergenic potency of these preparations needs to be assessed relative to patients' sensitivities to specific allergens (eg, peanut allergens Ara h 1, Ara h 2, and Ara h 6), which is not possible using a generic ELISA.
A quantitative mAb-based ELISA for Ara h 1 was previously used to monitor allergen levels in peanut-containing foods, including chocolate. 5, 6 Subsequently, this assay was used to investigate the effects of roasting on Ara h 1 levels in peanuts and expression of Ara h 1 in different peanut strains. 7 Measurements of Ara h 1 were also used as a surrogate marker in clinical studies to assess the distribution of peanut allergens in schools and to investigate the transmission of peanut through saliva by kissing or sharing utensils. 8, 9 Although Ara h 1 appeared to be a good marker for peanut, the assay sensitivity was somewhat low (approximately 30 ng/mL), which made it unsuitable for certain applications, such as environmental exposure assessments. It also became clear that Ara h 2 was the most important peanut allergen in terms of biological potency and diagnostic efficacy. 10 ,11 Ara h 6 is structurally related to Ara h 2 (50% amino acid identity) and has similar allergenic importance. 12 Both Ara h 2 and Ara h 6 are major allergens, eliciting IgE responses in 80% to 90% of patients with peanut allergy and showing potent 10,11 The 3-dimensional structures of Ara h 1, Ara h 2, and Ara h 6 have been determined, and these 3 allergens are well-defined molecular markers of peanut. 13, 14 Panels of mAbs to Ara h 2 and to Ara h 6 were used to develop sensitive ELISAs that were specific for each allergen. 11 The aim of the present study was to compare Ara h 1, Ara h 2, and Ara h 6 profiles in peanut foods (peanut butter, flour, and oil), as well as in allergenic products that are used for diagnostic purposes and in preparations that are used for OIT. The results show wide variation in the profiles of specific peanut allergens across these sources. They also suggest that specific allergen measurements can improve allergen standardization of peanut preparations used for diagnostic and therapeutic purposes.
METHODS

Peanut food products
Samples of commercial peanut butter (n 5 16), peanut flour (n 5 11), and refined or unrefined peanut oils (n 5 8) were purchased either from local supermarkets or online. Nonpeanut butter (n 5 16) and nonpeanut flour (n 5 9), including almond, hazelnut, cashew, walnut, pecan, soy, coconut, and garbanzo bean, were used as controls. Samples were selected to include representative store brands, as well as organic and artisanal products. A complete list of all the products tested is provided in Table E3 in this article's Online Repository at www.jacionline.org.
The National Institute for Standards and Technology Peanut Butter Standard Reference Material 2387 (NIST SRM 2387) was purchased from NIST (Gaithersburg, Md). This standard was established for validating methods for determining fatty acids, calories, vitamins, elements, amino acids, acrylamide, and other components. The NIST SRM 2387 was prepared from raw Florunner peanuts from several suppliers, which were roasted and then ground into creamy peanut butter. For further details, see the NIST SRM 2387 Certificate of Analysis at: https://www-s.nist.gov/srmors/certificates/ 2387.pdf.
Peanut allergenic products
Peanut skin test reagents were obtained from 2 US allergen manufacturers: Greer Laboratories (Lenoir, NC, now Stallergenes-Greer) and ALK-Abell o (Round Rock, Tex).
Peanut flour extracts (n 5 3) were prepared for use in clinical trials of OIT at the Division of Pediatric Allergy, University of Virginia Health Sciences Center (UVA), and at the Department of Pediatric Allergy, University of North Carolina at Chapel Hill (UNC). The UVA peanut OIT Study involved 20 children with peanut allergy aged 4 to 18 years who were enrolled in a pilot study of OIT (institutional review board #15098; ClinicalTrials.gov ID: NCT02350660). The peanut flour used in the study was obtained from the Greer Laboratories source materials department (product code RMF171P). A peanut protein extract solution was prepared according to the method of Jones et al. 15 Briefly, peanut proteins were extracted from the Greer-sourced peanut flour in PBS, clarified by means of centrifugation (30,000g for 30 minutes), and sterilized by means of filtration. Protein concentration was determined, and a stock solution was stored at 2208C. The UNC peanut OIT study enrolled 50 young children aged 9 to 36 months to determine the efficacy of OIT in terms of desensitization and sustained unresponsiveness (institutional review board #11-2307 and ClinicalTrials.gov ID: NCT00932828). 16 The peanut flour used in the study was a 12% fat light-roasted peanut flour and was obtained from the Golden Peanut Company (Alpharetta, Ga). The extract was prepared by using the same protocol as the extract produced at UVA. 15 
Immunoassays for peanut allergens
Measurements of Ara h 1, Ara h 2, and Ara h 6 were made by means of ELISA, as described previously. 5, 11 The Ara h 1 ELISA used mAb 2C12 for allergen capture and biotinylated mAb 2F7 for detection. The Ara h 2 ELISA used mAb 1C4 for allergen capture and polyclonal rabbit anti-Ara h 2 for detection. The Ara h 6 ELISA used mAb 3B8 for allergen capture and biotinylated mAb 3E12 for detection. Purified in-house natural Ara h 1 (Lot 35106), Ara h 2 (Lot 35139), and Ara h 6 (Lot 35006) were used as allergen standards for each assay. Protein content of the standards was determined either by means of amino acid analysis or absorption at 280 nm. Samples were typically diluted to 1:100 and assayed at doubling dilutions across the ELISA plate.
Peanut butter, flour, and powder samples and control samples were prepared by extracting 1-g aliquots in 10 mL of PBS (pH 7.4) containing 0.05% Tween 20 and 1 mol/L NaCl. Samples were extracted for 2 hours at room temperature and centrifuged at 150g for 20 minutes. Supernatants were stored at 2208C before analysis. The allergen content of peanut butter, flour, and powder samples was expressed as micrograms per gram of the actual food product extracted. Peanut oils were diluted 1:100 in PBS (pH 7.4), containing 0.05% Tween 20 before assay.
Selected peanut butter and peanut flour extracts were assayed for total peanut antigen by means of ELISA with a commercial kit (Veratox; Neogen, Lansing, Mich).
RESULTS
Allergen profiles of peanut food products
The availability of ELISAs for 3 major peanut allergens allowed quantitative comparisons of the allergen composition of peanut foodstuffs. Control curves for these assays were reproducible when different peanut flour extracts were compared, although with different levels of sensitivity: Ara h 1 has a lower limit of detection (LLOD) of 31 ng/mL, Ara h 2 has an LLOD of 2 ng/mL, and Ara h 6 has an LLOD of 0.8 ng/mL (Fig 1) . A peanut butter standard produced by the US National Institute of Standards and Technology, NIST SRM 2387, has been used by the food industry since 2003 for validating measurements of amino acids and other biochemical components of peanut butter. To our knowledge, NIST SRM 2387 is the only national standard for peanut butter (or any other peanut foodstuff). Control curves for the purified allergen standards, NIST SRM 2387, and selected peanut butter and peanut flour extracts were parallel (see Fig E1 in this article's Online Repository at www.jacionline.org). These results provided validation that the ELISA could be used to make quantitative measurements of specific peanut allergens in different peanut matrices. Assay performance was also evaluated by using spike recovery experiments with NIST SRM 2387 and peanut oil (see the Methods section in this article's Online Repository at www.jacionline.org). Recovery rates with both matrices ranged from 80% to 99% (see Table E1 ). Reproducibility of the assays and extraction procedures was also demonstrated by using NIST SRM 2387, further validating the robustness of the ELISA (see Table E2 in this article's Online Repository at www. jacionline.org).
Analysis of NIST SRM 2387 showed that it contained substantial amounts of Ara h 1, Ara h 2, and Ara h 6 (11,275 mg/g, 2,522 mg/g, and 2,036 mg/g, respectively) with high ratios of Ara h 1 to Ara h 2 (4.5) and Ara h 6 (5.3). The allergen profiles of 16 peanut butter samples showed significant variability in Ara h 1 levels (991-21,406 mg/g) and that Ara h 1 levels typically exceeded Ara h 2 and Ara h 6 levels by 2-to 4-fold (Table I) . High Ara h 1/Ara h 2 ratios were found in roasted peanut butter. Two samples of raw peanut butter (Essential Living Foods and Vivapura) contained much lower levels of Ara h 1 than Ara h 2 (ratio, 0.24), suggesting that roasting selectively increased measurable Ara h 1 levels in peanut butter. Overall, the Ara h 1/ Ara h 2 and Ara h 1/Ara h 6 ratios were 2.0 6 0.6 and 2.7 6 0.7, respectively. Ara h 6 levels were similar to Ara h 2 levels in the peanut butter samples and in other peanut foodstuffs analyzed in this study (Tables I and II) .
In contrast, peanut flour samples from 5 commercial sources contained higher levels of Ara h 2 (and Ara h 6) than Ara h 1 (9/11 [82%]). Moreover, Ara h 1 levels in peanut flour showed great variability (34-13,473 mg/g, Table II ). The lowest levels of Ara h 1 were found in ''dark roast'' peanut flour (34-122 mg/g) from 2 different suppliers. These samples also contained the lowest levels of Ara h 2, suggesting that dark roast processing significantly reduces overall allergen content. The mean Ara h 2/ Ara h 1 ratio in peanut flour samples was 7.3 6 5.6, with 3 samples containing 15-to 23-fold more Ara h 2 than Ara h 1 (Fig 2 and Table II ). Ara h 2 levels in ''light roast'' peanut flour showed greater consistency, especially 12% fat light roast flour, in which Ara h 1, Ara h 2, and Ara h 6 levels were of the same order of magnitude. Control curves for the light roast flours were similar (see Fig E1) , indicating that antigenic reactivity was retained after the roasting process.
Peanut content of flour samples was also compared by using one of the total peanut assays that are widely used in the food industry. The results did not correlate with the cumulative measurements of Ara h 1, Ara h 2, and Ara h 6 levels in flour samples. For example, the light roast and dark roast Golden flour samples varied by 14-fold in cumulative allergen content, yet had very similar measures of total peanut in parts per million (Table  II) . These results suggested that the total peanut ELISA was measuring peanut proteins other than the specific allergens measured in this study.
Control tree nut, soy nut, or sunflower seed butters were less than the detection limit for all 3 allergen assays or contained trace amounts of Ara h 2 (<0.8 mg/g). Significant Ara h 1 reactivity was detected in garbanzo bean/chickpea flour (14-16 mg/g, see Table  E3 ). Preliminary affinity purification data (not shown) suggest that garbanzo beans can produce an Ara h 1 homologue that would explain this apparent cross-reactivity.
Several peanut oils were tested, including unrefined, refined, and expeller pressed oils, which were labeled as such by the manufacturers. No detectable Ara h 1, Ara h 2, or Ara h 6 was found in 7 of 8 oils. All 3 allergens were detected at 6 to 10 mg/mL in one sample of roasted unfiltered oil, which contained a sediment of peanut solids (see Table E3 for the complete data set of allergen profiles of peanut foodstuffs that were tested in the study).
Diagnostic reagents and OIT formulations
Specific peanut allergens were measured in diagnostic skin test products from 2 US allergen manufacturers. The results showed that both manufacturers' test solutions contained high levels of Ara h 2 relative to Ara h 1, suggesting that they were prepared from peanut flour. The Ara h 2 levels of Manufacturer A skin test reagents were greater than 2,000 mg/mL, with approximately 50 mg/mL Ara h 1. The Ara h 2 levels of Manufacturer B skin test reagents were 200 to 700 mg/mL, with Ara h 1 ranging from 24 to 114 mg/mL (Table III) . The Ara h 2 levels for both manufacturers are very high for a diagnostic skin test solution and exceed, for example, the allergen levels found in standardized dust mite and cat allergenic products that are licensed by the US Food and Drug Administration. 17 It should be noted that Ara h 1 levels are also broadly comparable with those found in standardized skin test products.
OIT is being developed for the treatment and prevention of peanut allergy. Almost all peanut OIT studies use peanut flour to formulate food vehicles for treatment purposes. 15 The dose of peanut used is reported as milligrams of peanut flour, with a typical maintenance dose being 300 mg. Comparison of specific peanut allergen levels in flours used in 2 OIT trials showed 3-to 10-fold more Ara h 2 and Ara h 6 than Ara h 1 (Table IV) . The 2 samples from UNC showed good reproducibility. Ara h 2 and Ara h 6 levels in the UVA peanut vehicle were approximately 3-to 6-fold higher than those used by UNC, indicating that different cumulative doses of specific allergens were being used in these OIT trials.
DISCUSSION Allergen variance within and between peanut products
Ara h 1, Ara h 2, and Ara h 6 are immunodominant allergens among peanut-sensitive subjects. Here we show that the composition and concentrations of these 3 major allergens vary greatly in peanut butter, peanut powder, and, especially, peanut flour, in which specific allergen concentrations varied by as much as 20-fold. A striking feature of the results was that the levels of Ara h 1 in peanut butter were 2-to 4-fold higher than those of Ara h 2. This effect was most notable for the NIST SRM 2387 peanut butter standard that contained 4-to 5-fold more Ara h 1 than the other allergens. Conversely, Ara h 2 levels in peanut flour were up to 20-fold greater than those of Ara h 1. Ara h 6 levels closely paralleled those of Ara h 2 (for the purposes of this discussion, any comments related to Ara h 2 also apply to Ara h 6). Roasting has previously been shown to increase the apparent antigenicity of Ara h 1 in peanuts and to increase IgE binding to peanut extracts. 7, 18, 19 Thus high levels of Ara h 1 in peanut butter appear to be explained by the fact that the majority of the samples were prepared from roasted peanuts. The 2 peanut butter brands that used raw peanuts both contained 4-fold more Ara h 2 than Ara h 1 and had similar allergen profiles to peanut flour samples. For both peanut butter and peanut flour samples, there was reasonable consistency of allergen levels among multiple samples from the same food manufacturer. As expected, nonpeanut butter samples were essentially free of peanut allergens, thus confirming their utility as a substitute food for patients with peanut allergy. The molecular mechanisms of roasting and the effects of food processing in general on peanut allergens are poorly understood. Recent mass spectrometry studies have identified advanced glycation end-products, which modify lysine residues on Ara h 1 (and Ara h 3) but not Ara h 2. 20 IgE antibodies recognize both advanced glycation end-products-modified and unmodified Ara h 1, which suggests that other mechanisms contribute to foodprocessing effects on IgE and mAb binding.
The variability of Ara h 2 levels in peanut flour was largely attributable to dark roast flour containing either 12% or 28% fat. These samples had the lowest Ara h 2 levels but also had extremely low levels of Ara h 1, suggesting that dark roast processing degrades both allergens, especially Ara h 1. Although 12% fat light or dry roast peanut flours also had higher levels of Ara h 2, the differences in Ara h 2/Ara h 1 ratios were not as marked. and some samples contained similar levels for all 3 allergens (eg, Old Virginia Byrd Mill and Golden Peanut Company).
Comparison of testing modalities
Peanut flour is widely used in the food-manufacturing and processing industry and is incorporated into baked goods, confectionaries, and desserts. Trace contamination of other foods with peanut has traditionally been measured by using total peanut antigen ELISAs. The results show a weak correlation between total peanut protein levels and specific allergen content of peanut flour. Recent studies by Jayasena et al 21 compared the specificity and sensitivity of 6 commercial peanut ELISA kits for measuring Ara h 1, Ara h 2, Ara h 3, and Ara h 6. The data convincingly showed that 5 of 6 peanut ELISA kits measured predominantly Ara h 3, with weak reactivity to other allergens, whereas one kit predominantly measured Ara h 2 and Ara h 6. The total peanut kit that was used in the present study was an Ara h 3 kit, which explains why the results did not correlate with specific allergen data reported here. Almost all of the peanut flour samples were measured to contain more than 1,000,000 ppm total peanut in the commercial kit (Table II) . The most likely explanation for these results is that the flour samples contained higher concentrations of Ara h 3 than the assay standard for total peanut used in the kit.
Clinical significance of variability in peanut allergen levels
Peanut oils. The present analysis of allergen profiles in peanut foods was not designed to investigate whether the consumption of a particular peanut food might affect IgEmediated sensitization to a specific allergen or allergens. However, the results have some bearing on whether peanut oil contributes to allergenicity. Early studies indicated that peanut oil did not contain protein allergens. 22, 23 Subsequent studies reported that concentrated protein from peanut oil produced positive skin test results, leukocyte histamine release, and IgE inhibition activity in highly sensitive patients with peanut allergy. 24 Epidemiologic studies showed a significant correlation between positive peanut challenge test results in children and use of peanut creams or emollients that contained peanut oils. This led to the hypothesis that allergic sensitization to peanut occurred because of exposure to allergen through peanut oils present in creams and emollients that were applied to inflamed skin. 25 In the present study 7 of 8 peanut oils were less than the limit of detection in the Ara h 1, Ara h 2, and Ara h 6 ELISAs (ie, <8 ng/ mL for the most sensitive assay [Ara h 6]). All 3 allergens were detected at 6 to 10 mg/mL in unfiltered peanut oil, suggesting that the absence of allergen in refined peanut oils was not explained by the extraction methods used. The data are consistent with clinical studies that showed that highly refined peanut oils did not cause allergic reactions in double-blind crossover food challenge studies. 26 Although the possibility that peanut oil contains allergens other than those measured in this study cannot be excluded, this appears to be unlikely. Over the approximately 15 years since the earlier publications that reported allergens in peanut oil, manufacturers might have improved the refining process to remove all protein. Certainly, given the current results, creams and emollients could be tested for specific allergens to ascertain whether these products pose a significant exposure risk.
Diagnostic and therapeutic products. Peanut allergenic products for clinical use showed variability in allergen content. The diagnostic products had much lower levels of Ara h 1 than Ara h 2, raising questions about the source materials from which these extracts were prepared. The relative deficiency of Ara h 1 in skin test solutions is cause for concern, although the absolute concentrations of Ara h 1 in the extracts (24-114 mg/mL) are in line with those present in other US Food and Drug Administration-standardized allergenic products. Concerns about specific allergen content can also apply to use of peanut products for diagnostic peanut challenges. Double-blind, placebo-controlled food challenges typically use peanut flour, whereas peanut butter is often used in clinical practice or for open challenges in research. The stark differences in allergen content between these foods suggest a need for improved standardization and, possibly, manufacture of peanut food standards that can be used for challenge testing. Similarly, the data on allergen profiles of peanut vehicles used in OIT suggest a need for improved standardization of formulations used in clinical trials so that dosing regimens can be more directly compared.
Variability in the composition of peanut flour is clearly demonstrated in our studies. The results indicate that there could be differences in peanut allergen dosing in clinical trials depending on the manufacturer or supplier of the flour. Weight of flour per se in milligrams does not adequately reflect allergen content. By assessing the specific allergen profiles of OIT study materials, it will be possible to make more accurate and precise estimates of dosing and to determine effective allergen levels that are associated with tolerance to peanut. In a companion article we have estimated the doses of Ara h 1, Ara h 2, and Ara h 6 present in a peanut snack (Bamba) that were associated with the prevention of peanut allergy. 3, 27 The ability to compare specific antibody responses, cellular responses, and inflammatory markers with specific allergen concentrations in peanut vaccines will facilitate mechanistic studies of food allergy.
Limitations
One of the limitations of the present study was the limited number of diagnostic and OIT trial materials that were available for analysis. Given the increasing success of peanut OIT trials, more OIT products will become available for allergen testing. In addition, allergen measurements are now being used for assessing the dose of epicutaneous immunotherapy products. It can be envisioned that specific allergen profiles will be used increasingly for standardization purposes to improve the quality of peanut vehicles used for immunotherapy. Recent proteomic profiling of peanut allergens by using mass spectrometry further supports this approach. 28 
Conclusion
In conclusion, there are significant quantitative and qualitative differences in the specific allergen profiles of peanut-containing foods and in the ratios of Ara h 1 to Ara h 2 and Ara h 6. Allergen profiles are affected by roasting and fat composition (in peanut flour). Differences in allergen profiles are also apparent in diagnostic and therapeutic peanut allergen formulations. The data suggest that specific allergen measurements will improve standardization and provide valuable information on allergen dosing for optimal results in OIT as part of future trials. Recently, we have developed specific ELISAs for Ara h 3 and Ara h 8 that will expand the peanut allergen profile. These assays are also being developed on multiplex array platforms, so that all major peanut allergens can be profiled in a single assay. Peanut allergen profiling will expand the scope of peanut OIT studies so that immunologic and other responses to treatment can be directly correlated to the doses of specific allergens used for therapy or peanut allergy prevention.
METHODS
Assay procedure for spiking experiments
Extracts of NIST SRM 2387 peanut butter reference material and peanut oil (roasted, unrefined) were tested by means of ELISA to determine Ara h 1, Ara h 2, and Ara h 6 concentrations. The peanut butter extract was diluted 100-fold in ELISA buffer (0.05% PBS-Tween 20 and 1% BSA, pH 7.4) to achieve a concentration in the quantifiable range of each ELISA. The peanut oil was diluted 10-fold in assay buffer to provide a miscible sample. Control spikes were prepared in assay buffer by using purified natural Ara h 1, Ara h 2, and Ara h 6 (INDOOR Biotechnologies, Charlottesville, Va). Spike amounts for each allergen were as follows: Ara h 1, 850 ng/mL; Ara h 2, 125 ng/mL; and Ara h 6, 85 ng/mL. Spiked samples were prepared by mixing equal volumes of control spike and diluted peanut butter extract or peanut oil. Unspiked samples, spiked samples, and control spikes were tested at multiple dilutions by using ELISA. Plates were developed with ABTS and read at 405 nm on a microplate reader (BioTek Instruments, Winooski, Vt). Allergen concentrations were quantified by using Ara h 1, Ara h 2, and Ara h 6 allergen standards (see the Methods section).
FIG E1.
Comparison of control curves for allergen standards and peanut food extracts. Serial dilutions of allergen standards (red circles), NIST SRM 2387 (blue diamonds), peanut butter extracts (red triangles), and extracts of light roast (light green squares) or dark roast (dark green squares) peanut flour were compared in the Ara h 1, Ara h 2, and Ara h 6 ELISAs. These curves illustrate the greater sensitivity of the Ara h 2 and Ara h 6 ELISAs compared with Ara h 1. There was a high degree of parallelism between the assays, and in most cases the control curves were superimposable, except for dark roast peanut flour extract (Ara h 1).
J ALLERGY CLIN IMMUNOL VOLUME 141, NUMBER 2 Extracts of NIST SRM 2387 peanut butter reference material and peanut oil were spiked with Ara h 1, Ara h 2, and Ara h 6 and tested by means of ELISA to determine peanut allergen concentrations. Spike recovery was calculated by dividing the measured allergen concentration in spiked samples by the total theoretical concentration multiplied by 100. Allergen recovery from spiked samples ranged from 80% to 99%. On 3 separate days, 1 g of NIST peanut butter was weighed and then extracted in 10 mL of PBS with 0.05% Tween 20 for 2 hours at room temperature. Extracts were measured for Ara h 1, Ara h 2, and Ara h 6 levels by using ELISA. Boldface values indicate the highest and lowest concentrations of Ara h 1, Ara h 2, and Ara h 6 in the peanut butter and flour samples tested. DL, Detection limit.
